Presence of preexisting antibodies mediates survival in sepsis

Shock

Volumn 37, Issue 1, 2012, Pages 56-62

  Moitra, Rituparna ^a   Beal, Dominic R ^a   Belikoff, Bryan G ^a   Remick, Daniel G ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antibodies; cecal ligation and puncture; plasma enhanced killing; sepsis

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL SURVIVAL; BACTERICIDAL ACTIVITY; BLOOD; CECUM; CELL KILLING; COMPARATIVE STUDY; CONTROLLED STUDY; ENTEROBACTERIACEAE; FEMALE; FLOW CYTOMETRY; LIGATION; MOUSE; NEUTROPHIL; NONHUMAN; OPSONIZATION; PERITONEUM; PLASMA; PUNCTURE; SEPSIS; SURVIVAL;

ANIMALS; ANTIBODIES, BACTERIAL; DISEASE MODELS, ANIMAL; ENTEROBACTERIACEAE; FEMALE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MICE; MICE, INBRED ICR; NEUTROPHILS; SEPSIS;

EID: 83655167279     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3182356f3e     Document Type: Article

References (33)

1. Angus DC, Pereira CA, Silva E: Epidemiology of severe sepsis around the world. Endocr Metab Immune Disord Drug Targets 6(2):207-212, 2006. (Pubitemid 43881034)
2. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29(7):1303-1310, 2001. (Pubitemid 32641789)
3. Angus DC, Wax RS: Epidemiology of sepsis: an update. Crit Care Med 29(Suppl 7):S109-S116, 2001. (Pubitemid 32681592)
4. Quartin AA, Schein RM, Kett DH, Peduzzi PN: Magnitude and duration of the effect of sepsis on survival. Department of Veterans Affairs Systemic Sepsis Cooperative Studies Group. JAMA 277(13):1058-1063, 1997. (Pubitemid 27147544)
5. Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348(16):1546-1554, 2003. (Pubitemid 36437931)
6. Russell JA: Management of sepsis. N Engl J Med 355(16):1699-1713, 2006. (Pubitemid 44583960)
7. Perl TM: Long-term survival and function after suspected gram-negative sepsis. JAMA 274(4):338-345, 1995.
8. Wichterman KA, Baue AE, Chaudry IH: Sepsis and septic shockVa review of laboratory models and a proposal. J Surg Res 29(2):189-201, 1980. (Pubitemid 10039498)
9. Remick DG: Pathophysiology of Sepsis. Am J Pathol 170(5):1435-1444, 2007. (Pubitemid 47339289)
10. Ebong SJ, Call DR, Bolgos G, Newcomb DE, Granger JI, O'Reilly M, Remick DG: Immunopathologic Responses to non-lethal sepsis. Shock 12(2):118-126, 1999.
11. Xiao H, Siddiqui J, Remick DG: Mechanisms of mortality in early and late sepsis. Infect Immun 74(9):5227-5235, 2006. (Pubitemid 44300441)
12. Remick DG, Bolgos G, Copeland S, Siddiqui J: Role of interleukin-6 in mortality from and physiologic response to sepsis. Infect Immun 73(5):2751-2757, 2005. (Pubitemid 40570341)
13. Osuchowski MF, Craciun FL, Schuller E, Sima C, Gyurko R, Remick DG: Untreated type 1 diabetes increases sepsis-induced mortality without inducing a prelethal cytokine response. Shock 34(4):369-376, 2010.
14. Osuchowski MF, Welch K, Yang H, Siddiqui J, Remick DG: Chronic sepsis mortality characterized by an individualized inflammatory response. J Immunol 179(1):623-630, 2007. (Pubitemid 46986580)
15. Craciun FL, Schuller ER, Remick DG: Early enhanced local neutrophil recruitment in peritonitis-induced sepsis improves bacterial clearance and survival. J Immunol 185(11):6930-6938, 2010.
16. Nemzek JA, Siddiqui J, Remick DG: Development and optimization of cytokine ELISAs using commercial antibody pairs. J Immunol Methods 255(1-2): 149-157, 2001. (Pubitemid 32695391)
17. Remick DG, Bolgos GR, Siddiqui J, Shin J, Nemzek JA: Six at six: interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 days. Shock 17(6):463-467, 2002.
18. van Griensven M, Probst C, Muller K, Hoevel P, Pape HC: Leukocyteendothelial interactions via ICAM-1 are detrimental in polymicrobial sepsis. Shock 25(3):254-259, 2006.
19. Tschöp J, Nogueiras R, Haas-Lockie S, Kasten KR, Castañeda TR, Huber N, Guanciale K, Perez-Tilve D, Habegger K, Ottaway N, et al.: CNS leptin action modulates immune response and survival in sepsis. J Neurosci 30(17): 6036-6047, 2010.
20. De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, Brasseur A, Defrance P, Gottignies P, Vincent JL, et al.: Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 362(9):779-789, 2010.
21. Irwin PL, Nguyen LH, Paoli GC, Chen CY: Evidence for a bimodal distribution of Escherichia coli doubling times below a threshold initial cell concentration. BMC Microbiol 10:207, 2010.
22. Newcomb D, Bolgos G, Green L, Remick DG: Antibiotic treatment influences outcome in murine sepsis: mediators of increased morbidity. Shock 10(2): 110-117, 1998. (Pubitemid 128463842)
23. Belikoff B, Hatfield S, Sitkovsky M, Remick DG: Adenosine negative feedback on a2a adenosine receptors mediates hyporesponsiveness in chronically septic mice. Shock 35(4):382-387, 2011.
24. Vianna RC, Gomes RN, Bozza FA, Amâncio RT, Bozza PT, David CM, Castro-Faria-Neto HC: Antibiotic treatment in a murine model of sepsis: impact on cytokines and endotoxin release. Shock 21(2):115-120, 2004.
25. Schwartz-Albiez R, Monteiro RC, Rodriguez M, Binder CJ, Shoenfeld Y: Natural antibodies, intravenous immunoglobulin and their role in autoimmunity, cancer and inflammation. Clin Exp Immunol 158(Suppl 1):43-50, 2009.
26. Boes M: Role of natural and immune IgM antibodies in immune responses. Mol Immunol 37(18):1141-1149, 2000.
27. Boes M, Prodeus AP, Schmidt T, Carroll MC, Chen J: A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med 188(12):2381-2386, 1998. (Pubitemid 29028511)
28. Zhang M, Michael LH, Grosjean SA, Kelly RA, Carroll MC, Entman ML: The role of natural IgM in myocardial ischemia-reperfusion injury. J Mol Cell Cardiol 41(1):62-67, 2006. (Pubitemid 43946958)
29. Ochsenbein AF, Fehr T, Lutz C, Suter M, Brombacher F, Hengartner H, Zinkernagel RM: Control of early viral and bacterial distribution and disease by natural antibodies. Science 286(5447):2156-2159, 1999. (Pubitemid 129516290)
30. Wang H, Ward MF, Sama AE: Novel HMGB1-inhibiting therapeutic agents for experimental sepsis. Shock 32(4):348-357, 2009.
31. Hagiwara S, Iwasaka H, Hasegawa A, Asai N, Noguchi T: High-dose intravenous immunoglobulin G improves systemic inflammation in a rat model of CLP-induced sepsis. Intensive Care Med 34(10):1812-1819, 2008.
32. Ray TD, Lewis LA, Gulati S, Rice PA, Ram S: Novel blocking human IgG directed against the pentapeptide repeat motifs of Neisseria meningitidis Lip/H.8 and Laz lipoproteins. J Immunol 186(8):4881-4894, 2011.
33. Taccone FS, Stordeur P, De Backer D, Creteur J, Vincent JL: gamma-Globulin levels in patients with community-acquired septic shock. Shock 32(4):379-385, 2009.